F3Logic’s PRA Health Sciences, Inc. PRAH Stock Holding History

F3Logic’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4	Closed	-$406	–	464
2020 Q3	$406	Buy	+4	New	+$408	0.01%	374

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

F3Logic's PRAH Position: Q4 2020 in Review

F3Logic sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 4 shares — an estimated $406 sold.

F3Logic first reported a position in PRAH in Q3 2020 and held it in 1 quarter. The position peaked at $406 in Q3 2020. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

F3Logic reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
F3Logic sold 4 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $406.
F3Logic first reported a position in PRA Health Sciences, Inc. in Q3 2020 and held it in 1 quarter.
F3Logic's PRA Health Sciences, Inc. position peaked at $406 in Q3 2020.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on F3Logic's 13F filing for Q4 2020, filed 12 Feb 2021.